GGrantIndex
← Leaderboards

Maria Hadjifrangiskou

Vanderbilt University

$5,894,528
Attributed
$5,894,528
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY201525
$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$6,574,528 · 7

By mechanism

R01$4,237,966 · 2
P20$1,360,000 · 3
R21$976,562 · 2

Top collaborators

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Infection

Research focus

InfectionPathogenesisPathogenUrinary Tract InfectionEnvironmentPreventBladderUrinary TractMutantIn VitroEscherichia ColiWomanIn VivoResourcesMolecularLinkBacteriaUropathogenic E. ColiCommunitiesGenitourinary SystemCombatGenesFosteringInsight

Grant awards (20)

How E. coli Acid Response Mechanisms Breach Colonization Resistance in the Vagina$584,684
R01 · FY2025 · AI · contact PI
Pseudomonas pathogenesis in the bladder$212,672
R21 · FY2025 · AI · contact PI
How E. coli Acid Response Mechanisms Breach Colonization Resistance in the Vagina$589,124
R01 · FY2024 · AI · contact PI
Pseudomonas pathogenesis in the bladder$275,172
R21 · FY2024 · AI · contact PI
Targeting cytochrome bd as an anti-biofilm strategy$213,109
R21 · FY2024 · AI · contact PI
How E. coli Acid Response Mechanisms Breach Colonization Resistance in the Vagina$555,101
R01 · FY2023 · AI · contact PI
Targeting cytochrome bd as an anti-biofilm strategy$275,609
R21 · FY2023 · AI · contact PI
How E. coli Acid Response Mechanisms Breach Colonization Resistance in the Vagina$574,036
R01 · FY2022 · AI · contact PI
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery$340,000
P20 · FY2020 · DK · contact PI
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery$252,385
P20 · FY2020 · DK · contact PI
Administration and Regulation of Activities associated with The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery$87,615
P20 · FY2020 · DK · contact PI
Two-component system interactions as uropathogenic Escherichia coli drug targets$394,304
R01 · FY2019 · AI · contact PI
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery$340,000
P20 · FY2019 · DK · contact PI
The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery$239,765
P20 · FY2019 · DK · contact PI
Administration and Regulation of Activities associated with The Vanderbilt Urologic Infection Repository, a Resource for Personalized Clinical Discovery$100,235
P20 · FY2019 · DK · contact PI
Two-component system interactions as uropathogenic Escherichia coli drug targets$394,304
R01 · FY2018 · AI · contact PI
Two-component system interactions as uropathogenic Escherichia coli drug targets$394,304
R01 · FY2017 · AI · contact PI
Two-component system interactions as uropathogenic Escherichia coli drug targets$253,593
R01 · FY2016 · AI · contact PI
Two-component system interactions as uropathogenic Escherichia coli drug targets$139,828
R01 · FY2016 · AI · contact PI
Two-component system interactions as uropathogenic Escherichia coli drug targets$358,688
R01 · FY2015 · AI · contact PI